---
figid: PMC5560156__jcav08p2369g001
figtitle: Schematic overview of the molecular network involved in VSV oncoselectivity
organisms:
- Human alphaherpesvirus 1
- Vesicular stomatitis virus
- Vaccinia virus
- Human T-cell leukemia virus type I
- Moloney murine leukemia virus
- Measles morbillivirus
- Betapolyomavirus macacae
- Reovirus sp.
- Human adenovirus 5
- Foot-and-mouth disease virus
- Human rhinovirus sp.
- Myxoma virus
- Poliovirus 2
- rhinovirus A2
- Vaccinia virus GLV-1h68
- Maraba virus
- Vaccinia virus Ankara
- Homo sapiens
- Mus musculus
- Canis lupus familiaris
- Scutellaria baicalensis
- NA
- NA
- NA
- NA
pmcid: PMC5560156
filename: jcav08p2369g001.jpg
figlink: /pmc/articles/PMC5560156/figure/F1/
number: F1
caption: 'A schematic overview of the molecular network involved in VSV oncoselectivity.
  Binding of growth factors to the receptor tyrosine kinase (RTK) activates the receptor
  complex, which in turn recruits and activates PI3K. Activated PI3K converts PIP2
  to PIP3, which subsequently mediates the phosphorylation of AKT. Tumor suppressor
  PTEN negatively regulates the pathway by removing the 3-phosphate from PIP3, converting
  it back to PIP2. PTEN is crucial for the activation of IRF3, its import into the
  nucleus and production of IFN-β. Loss of PTEN leads to over-activation of AKT and
  subsequently mTOR, which is associated with uncontrolled cell growth, proliferation,
  and survival. PTEN loss leads also to the development of cancer stem cells (CSCs)
  and an impaired cellular responses to viral infection. Up-regulation of LDLR in
  ovarian carcinomas enables VSV to enter cells with altered PTEN function through
  LDLR. Abbreviations: PI3K, phosphatidylinositol 3-kinase; PIP2, phosphatidylinositol
  (4,5)-bisphosphate); PIP3, phosphatidylinositol (3,4,5)-trisphosphate); AKT, serine/threonine
  kinase; IRF3, interferon regulatory factor-3; mTOR, mammalian target of rapamycin;
  LDLR, low-density lipoprotein receptor. See text for further details.'
papertitle: 'VSV based virotherapy in ovarian cancer: the past, the present and …future?.'
reftext: Beata Urszula Orzechowska, et al. J Cancer. 2017;8(12):2369-2383.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9599966
figid_alias: PMC5560156__F1
figtype: Figure
organisms_ner:
- Canis lupus familiaris
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC5560156__F1
ndex: 6a754ea3-dede-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5560156__jcav08p2369g001.html
  '@type': Dataset
  description: 'A schematic overview of the molecular network involved in VSV oncoselectivity.
    Binding of growth factors to the receptor tyrosine kinase (RTK) activates the
    receptor complex, which in turn recruits and activates PI3K. Activated PI3K converts
    PIP2 to PIP3, which subsequently mediates the phosphorylation of AKT. Tumor suppressor
    PTEN negatively regulates the pathway by removing the 3-phosphate from PIP3, converting
    it back to PIP2. PTEN is crucial for the activation of IRF3, its import into the
    nucleus and production of IFN-β. Loss of PTEN leads to over-activation of AKT
    and subsequently mTOR, which is associated with uncontrolled cell growth, proliferation,
    and survival. PTEN loss leads also to the development of cancer stem cells (CSCs)
    and an impaired cellular responses to viral infection. Up-regulation of LDLR in
    ovarian carcinomas enables VSV to enter cells with altered PTEN function through
    LDLR. Abbreviations: PI3K, phosphatidylinositol 3-kinase; PIP2, phosphatidylinositol
    (4,5)-bisphosphate); PIP3, phosphatidylinositol (3,4,5)-trisphosphate); AKT, serine/threonine
    kinase; IRF3, interferon regulatory factor-3; mTOR, mammalian target of rapamycin;
    LDLR, low-density lipoprotein receptor. See text for further details.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LDLR
  - RIGI
  - PTEN
  - TBK1
  - IRF3
  - MTOR
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IFIH1
  - AKT1
  - AKT2
  - AKT3
  - IFNB1
  - Ldlr
  - Pik3r1
  - Rigi
  - Ifih1
  - Pten
  - Tbk1
  - Akt1
  - Irf3
  - Mtor
  - Ifnb1
---
